U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06822868) titled 'A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma' on Feb. 05.
Brief Summary: A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
Study Start Date: Feb. 10
Study Type: INTERVENTIONAL
Condition:
B-Cell Non-Hodgkin Lymphoma
Intervention:
DRUG: CAR T cells
chimeric antigen receptor T cells
Recruitment Status: RECRUITING
Sponsor: Kai Hu
Information provided by (Responsible Party): Kai Hu, Beijing GoBroad Hospital
Published by HT Digital Co...